Effect of early use of ivabradine on left ventricular remodeling after primary percutaneous coronary intervention in patients with acute ST‐segment elevation myocardial infarction: A pilot test

Autor: Wenying Zhang, Qiang Liu, Yan Xu, Xinlin Luo, Xinbo Zhong, Shaodi Yan, Ruirui Guo, Haijun Chen
Rok vydání: 2020
Předmět:
Male
medicine.medical_specialty
medicine.medical_treatment
Pilot Projects
030204 cardiovascular system & hematology
Ventricular Function
Left
03 medical and health sciences
Percutaneous Coronary Intervention
0302 clinical medicine
Physiology (medical)
Internal medicine
Heart rate
medicine
Humans
Ivabradine
cardiovascular diseases
030212 general & internal medicine
Myocardial infarction
Ventricular remodeling
Metoprolol
left ventricular remodeling
Ejection fraction
Ventricular Remodeling
emergency
business.industry
Percutaneous coronary intervention
Cardiovascular Agents
Original Articles
General Medicine
Middle Aged
medicine.disease
Treatment Outcome
myocardial infarction
Acute Disease
Conventional PCI
Cardiology
ST Elevation Myocardial Infarction
Female
Original Article
percutaneous coronary intervention (PCI)
Cardiology and Cardiovascular Medicine
business
medicine.drug
Zdroj: Annals of Noninvasive Electrocardiology
ISSN: 1542-474X
1082-720X
DOI: 10.1111/anec.12816
Popis: Objective To investigate the effect of early use of ivabradine on left ventricular remodeling after primary percutaneous coronary intervention (PCI) in patients with acute ST‐segment elevation myocardial infarction (STEMI). Methods A total of 66 STEMI patients with sinus rhythm and the resting heart rate ≥80 bpm after successful emergency PCI were included. The patients in the test group were treated with ivabradine combined with metoprolol at 12 hr after PCI, while the control group was given only metoprolol orally. Their resting heart rate was controlled to
Databáze: OpenAIRE
Externí odkaz: